Sign up to save your podcasts
Or
Share The Altissimo Study using a TKI for nAMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Altissimo Study using a TKI for nAMD
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
View all episodes
By Retina Synthesis
4.5
88 ratings
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
More shows like Retina Synthesis
View all
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners